Rising Demand for Cloud Biology Augmenting the European Biological Data Visualization Market
The European biological data visualization market is projected to grow at a significant CAGR during the forecast period (2020-2026). The growing adoption of cloud biology solutions in the region further contributes to the growing demand for biological data visualization tools in the country. The pharmaceutical companies in the region are significantly adopting cloud platforms for drug discovery and development that further required biological data visualization solutions for genome analysis and other applications.
Browse the full report description European Biological Data Visualization Market Size, Share & Trends Analysis Report by Technology (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals, and Clinics) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-biological-data-visualization-market
Several pharmaceutical companies, including Novartis International AG, AstraZeneca PLC, Evotec AG, Boehringer Ingelheim GmbH, Bayer AG, Ipson Group, and Janssen Pharmaceutical NV are using cloud platforms to carry new insights and knowledge into several stages of the drug discovery and development process.
Moreover, there is an increasing number of projects for research of microbiomes in numerous countries across the region including France and Germany. Microbiome sequencing technology handles a huge amount of data, which raises the need for proper analysis to have better results and study of the microbes.
The cloud computing platforms offer a space to handle such a huge amount of data from the collected samples of microbes and generate an effective result. Therefore, the presence of key research projects related to genomics, proteomics analysis is anticipated to create demand for data visualization tools for the generation of effective sequencing results by effective interpretation of the stored data.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Technology, by Application, and by End-User |
|
Regions Covered |
UK, Germany, France, Italy, Spain, and the Rest of Europe |
|
Key Companies Profiled |
Agilent Technologies, Inc., Becton, Dickinson and Co., Bruker Corp., Danaher Corp., Thermo Fisher
Scientific, Inc., Molecular Devices, LLC, and others |
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
European Biological Data Visualization Market – Segmentation
By Technology
- Magnetic Resonance Imaging
- Microscopy
- Sequencing
- Others(X-ray Crystallography)
By Application
- Genomic Analysis
- Cell Biology
- Molecular and Structural Analysis
- Others( Alignments, Phylogeny)
By End-User
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Hospitals and Clinics
European Biological Data Visualization Market – Segmentation by Geography
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-biological-data-visualization-market